← Home
🚀 Sign up Free for Public Company Valuation & Insights!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free Video Highlights
Eli Lilly and Company
+14.29%
Pharma / Pharma
At a Glance | Core Facts | Company Due Diligence: | Industry Due Diligence: | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebOverview
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana. It was founded in 1876 by Colonel Eli Lilly, a pharmaceutical chemist, and is one of the largest pharmaceutical companies in the world.
The company's primary focus is on the development and production of prescription medications in various therapeutic areas, including neuroscience, oncology, immunology, and diabetes. Some of its most well-known products include the antidepressant Prozac, the erectile dysfunction drug Cialis, and the insulin Humalog.
Eli Lilly and Company also has a strong global presence, with operations in over 125 countries and sales in more than 120 countries. The company has a long history of innovation and has been responsible for groundbreaking medical discoveries, such as the first commercially available insulin in 1923.
In addition to its pharmaceutical business, Eli Lilly and Company also has a strong commitment to corporate responsibility and sustainability. The company has implemented various initiatives to reduce its environmental impact, improve access to healthcare, and support local communities.
Eli Lilly and Company employs over 35,000 people worldwide and has been consistently ranked as one of the top places to work by various publications. The company continues to invest in research and development to bring new and innovative treatments to patients around the world.
The company's primary focus is on the development and production of prescription medications in various therapeutic areas, including neuroscience, oncology, immunology, and diabetes. Some of its most well-known products include the antidepressant Prozac, the erectile dysfunction drug Cialis, and the insulin Humalog.
Eli Lilly and Company also has a strong global presence, with operations in over 125 countries and sales in more than 120 countries. The company has a long history of innovation and has been responsible for groundbreaking medical discoveries, such as the first commercially available insulin in 1923.
In addition to its pharmaceutical business, Eli Lilly and Company also has a strong commitment to corporate responsibility and sustainability. The company has implemented various initiatives to reduce its environmental impact, improve access to healthcare, and support local communities.
Eli Lilly and Company employs over 35,000 people worldwide and has been consistently ranked as one of the top places to work by various publications. The company continues to invest in research and development to bring new and innovative treatments to patients around the world.
What is special about the company?
1. Long history: Eli Lilly and Company has a rich history dating back to its founding in 1876 by Colonel Eli Lilly. Over the years, the company has overcome numerous challenges and adapted to changing market conditions, making it one of the oldest and most enduring pharmaceutical companies in the world.
2. Diverse portfolio: The company has a diverse portfolio of products, encompassing a wide range of therapeutic areas such as neuroscience, endocrinology, oncology, and immunology. This provides a solid foundation for sustained growth and profitability.
3. Strong R&D focus: Eli Lilly and Company invests heavily in research and development, constantly seeking new treatments and cures for illnesses. The company spends billions of dollars each year on R&D and has a robust pipeline of potential new drugs.
4. Global reach: With operations in over 125 countries, Eli Lilly and Company has a truly global footprint. This allows the company to reach a wide market and maintain a strong presence in both developed and emerging markets.
5. Commitment to innovation: The company has a strong track record of innovation, bringing life-changing treatments to market. Eli Lilly and Company has a culture that encourages risk-taking and creativity, and invests in emerging technologies to drive innovation.
6. Social responsibility: Eli Lilly and Company has a strong sense of social responsibility and is committed to improving the well-being of communities where it operates. The company has initiatives focused on providing access to medicines for underserved populations, reducing its environmental footprint, and promoting diverse and inclusive workplaces.
7. Strong financial performance: Over the years, the company has maintained a solid financial performance despite challenging market conditions. Eli Lilly and Company has consistently delivered strong revenue growth and profitability, making it a financially stable and reliable company.
8. Employee-centric culture: The company values its employees and has a strong focus on creating a positive work environment. Eli Lilly and Company offers competitive benefits, opportunities for career growth, and a supportive and inclusive culture that fosters innovation and collaboration.
2. Diverse portfolio: The company has a diverse portfolio of products, encompassing a wide range of therapeutic areas such as neuroscience, endocrinology, oncology, and immunology. This provides a solid foundation for sustained growth and profitability.
3. Strong R&D focus: Eli Lilly and Company invests heavily in research and development, constantly seeking new treatments and cures for illnesses. The company spends billions of dollars each year on R&D and has a robust pipeline of potential new drugs.
4. Global reach: With operations in over 125 countries, Eli Lilly and Company has a truly global footprint. This allows the company to reach a wide market and maintain a strong presence in both developed and emerging markets.
5. Commitment to innovation: The company has a strong track record of innovation, bringing life-changing treatments to market. Eli Lilly and Company has a culture that encourages risk-taking and creativity, and invests in emerging technologies to drive innovation.
6. Social responsibility: Eli Lilly and Company has a strong sense of social responsibility and is committed to improving the well-being of communities where it operates. The company has initiatives focused on providing access to medicines for underserved populations, reducing its environmental footprint, and promoting diverse and inclusive workplaces.
7. Strong financial performance: Over the years, the company has maintained a solid financial performance despite challenging market conditions. Eli Lilly and Company has consistently delivered strong revenue growth and profitability, making it a financially stable and reliable company.
8. Employee-centric culture: The company values its employees and has a strong focus on creating a positive work environment. Eli Lilly and Company offers competitive benefits, opportunities for career growth, and a supportive and inclusive culture that fosters innovation and collaboration.
What the company's business model?
Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and marketing innovative medicines to improve people's lives. The company's business model is to invest heavily in research and development to create new drugs and treatments for a variety of medical conditions. This is done through a combination of internal research efforts, partnerships with other companies, and acquisitions of smaller biotech firms.
Eli Lilly's business model also includes a strong focus on marketing and branding to effectively promote its products and build brand recognition. The company heavily invests in sales and marketing efforts, including direct-to-consumer advertising and partnerships with healthcare providers.
In addition to developing and selling prescription medicines, Eli Lilly also has a business segment dedicated to animal health products, which includes vaccines and prescription medicines for pets and livestock.
The company's business model also includes a strong commitment to corporate social responsibility, with a focus on sustainable and ethical practices, charitable giving, and community involvement.
Overall, Eli Lilly's business model is centered on scientific innovation, strategic partnerships, effective marketing, and a commitment to social responsibility, all with the goal of improving patient health and well-being.
Eli Lilly's business model also includes a strong focus on marketing and branding to effectively promote its products and build brand recognition. The company heavily invests in sales and marketing efforts, including direct-to-consumer advertising and partnerships with healthcare providers.
In addition to developing and selling prescription medicines, Eli Lilly also has a business segment dedicated to animal health products, which includes vaccines and prescription medicines for pets and livestock.
The company's business model also includes a strong commitment to corporate social responsibility, with a focus on sustainable and ethical practices, charitable giving, and community involvement.
Overall, Eli Lilly's business model is centered on scientific innovation, strategic partnerships, effective marketing, and a commitment to social responsibility, all with the goal of improving patient health and well-being.
Interesting facts about the company
1. Eli Lilly and Company is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana.
2. The company was founded in 1876 by Colonel Eli Lilly, a pharmaceutical chemist, and is still named after him.
3. In its early years, Eli Lilly and Company primarily produced medicines derived from animal organs, such as insulin from the pancreas of cows and pigs.
4. Today, Eli Lilly and Company is one of the largest and most successful pharmaceutical companies in the world. It is estimated to be worth over $150 billion.
5. The company has a strong focus on research and development of new treatments for various diseases, with over 7,000 scientists and researchers employed globally.
6. Eli Lilly and Company is most well-known for its development and production of Prozac, a popular antidepressant medication, in the late 1980s.
7. The company has also made significant contributions in the fields of diabetes, cancer, and neuroscience treatments.
8. Eli Lilly and Company has a presence in over 125 countries and sells products in approximately 120 countries worldwide.
9. The company has a long history of philanthropy, with a focus on improving global health and supporting communities. It has donated over $700 million in products and cash to various organizations and initiatives since 2004.
10. In 2020, Eli Lilly and Company was involved in the development of an antibody treatment for COVID-19, which was granted emergency use authorization by the U.S. Food and Drug Administration.
See Company Due Diligence:
2. The company was founded in 1876 by Colonel Eli Lilly, a pharmaceutical chemist, and is still named after him.
3. In its early years, Eli Lilly and Company primarily produced medicines derived from animal organs, such as insulin from the pancreas of cows and pigs.
4. Today, Eli Lilly and Company is one of the largest and most successful pharmaceutical companies in the world. It is estimated to be worth over $150 billion.
5. The company has a strong focus on research and development of new treatments for various diseases, with over 7,000 scientists and researchers employed globally.
6. Eli Lilly and Company is most well-known for its development and production of Prozac, a popular antidepressant medication, in the late 1980s.
7. The company has also made significant contributions in the fields of diabetes, cancer, and neuroscience treatments.
8. Eli Lilly and Company has a presence in over 125 countries and sells products in approximately 120 countries worldwide.
9. The company has a long history of philanthropy, with a focus on improving global health and supporting communities. It has donated over $700 million in products and cash to various organizations and initiatives since 2004.
10. In 2020, Eli Lilly and Company was involved in the development of an antibody treatment for COVID-19, which was granted emergency use authorization by the U.S. Food and Drug Administration.
See Company Due Diligence:
Wait! There's more — sign up for free or log in